On Research - with CITI Program

The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast

June 25, 2024 CITI Program Season 2 Episode 6
The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast
On Research - with CITI Program
More Info
On Research - with CITI Program
The Evolution of IRBs: Navigating Ethical Considerations in Research - On Research Podcast
Jun 25, 2024 Season 2 Episode 6
CITI Program

Join us for a thoughtful, long-form discussion about the evolving IRB Industry.  Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process. 
 

Additional Resources: 

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.    

Show Notes Chapter Markers

Join us for a thoughtful, long-form discussion about the evolving IRB Industry.  Julie Blasingim, the CEO of Univo IRB, sits down to talk about how we got to the current IRB landscape we have now, and the future of IRBs. She covers a lot of areas related to the IRB, including how for-profit IRBs balance ethical reviews with the economics of business, identifying the gap between patients and the IRB process, as well as some hot topics for the IRB, like growing privacy protection concerns and the impact of AI on the IRB process. 
 

Additional Resources: 

Guest Bio: Julie Blasingim, CEO of Univo IRB, is a seasoned IRB executive with 20 years of extensive regulatory, operational, and compliance experience in human research protection and site operations of clinical research. She has served in a dozen senior leadership roles across multiple central IRBs, has hosted countless FDA inspections at both the IRB and under-site operations, and has managed multiple accreditations and certifications through AAHRPP and ISO. Julie holds a master’s degree in business administration specializing in leadership.    

Introduction to Julie Blasingim
Julie's Journey into the Research Industry
Evolution of Independent IRBs
IRB Landscape Changes
Managing Ethical Concerns in For-Profit
Disconnect Between IRBs and Patients
IRBs' Unique Position
Patient-Centric Approach
IRBs' Evolution
Ethical Concerns in Research
IT Security and IRB Boards
AI Impact on IRBs
Ethical Framework and Decision-Making
Balancing Risk and Patient Empowerment
Same Team: Impactful Research
Closing Remarks